Could a pill ease sleep apnea? new trial investigates
NCT ID NCT05612594
Summary
This study is testing if a drug called bexagliflozin, already used for diabetes, can help reduce the severity of sleep apnea. Over 160 overweight or obese adults with moderate to severe sleep apnea will take either the drug or a placebo pill daily for six months. Researchers will measure changes in breathing during sleep, body fat, and sleep quality to see if the drug helps.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLEEP APNEA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospitals Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106, United States
-
Yale New Haven Health
RECRUITINGNew Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.